Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Metro Healthcare Indonesia Tbk's quarterly Ending Cash Position
increased
from Dec. 2025 (Rp420,204 Mil) to Mar. 2026 (Rp421,768 Mil) but then
declined
from Mar. 2026 (Rp421,768 Mil) to Jun. 2026 (Rp414,280 Mil).
PT Metro Healthcare Indonesia Tbk's annual Ending Cash Position
declined
from Dec. 2023 (Rp525,763 Mil) to Dec. 2024 (Rp449,070 Mil) and
declined
from Dec. 2024 (Rp449,070 Mil) to Dec. 2025 (Rp420,204 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk Ending Cash Position Chart
PT Metro Healthcare Indonesia Tbk Ending Cash Position Calculation
Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.
What does a Ending Cash Position of Rp414,280 Mil mean?
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Ending Cash Position of Rp414,280 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors.
Is PT Metro Healthcare Indonesia Tbk's Ending Cash Position too high?
PT Metro Healthcare Indonesia Tbk's current Ending Cash Position is Rp414,280 Mil. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Ending Cash Position compare to HCA and THC?
PT Metro Healthcare Indonesia Tbk's Ending Cash Position of Rp414,280 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. PT Metro Healthcare Indonesia Tbk's current Ending Cash Position is Rp414,280 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp368.94, compared to a current price of Rp456.00 — trading 23.6% above its estimated fair value. The current Ending Cash Position is Rp414,280 Mil. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Ending Cash Position is Rp414,280 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp456.00 is trading 23.6% above its estimated GF Value™ of Rp368.94.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.
Key valuation signals for ISX:CARE:
Ending Cash Position: Rp414,280 Mil
GF Value™: Rp368.94 vs. price of Rp456.00 (23.6% above fair value)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
67GF Score
Get the complete analysis for ISX:CARE
Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
